InvestorsHub Logo
Followers 743
Posts 62148
Boards Moderated 11
Alias Born 10/05/2009

Re: bobw1951 post# 19858

Wednesday, 05/24/2023 11:30:11 PM

Wednesday, May 24, 2023 11:30:11 PM

Post# of 20024
Nope.

1) Where is the proof of this claim from UPennMed?

"NDT Pharmaceuticals, Inc has acquired all rights under a Sponsored Research Agreement with the University of Pennsylvania, including rights to use the University's NPC technology and Intellectual Property."

Show us proof, before OTC Markets even considers the lifting of CE.

Then show us what the UPennMed "University's NPC technology and Intellectual Property" actually is?

On UPennMed paper work.

What is it worth? What can it be worth?

Right Now I do not trust the less than 5% insiders not to dump shares once the CE is gone. Or shorts not to murder the value retail spent 3 Million dollars building up in NDTP since 2020.

Right now all the Insiders shares seem to be 1000x over issued in volume and or 1000X overvalued, and issued after retail got a 1000X hair cut. Looks like white collar crime to me, smells like white collar crime, and I am sure a jury would agree.

Retail supported the share price at up $10.90/share while it was allowed to have bid support, to the tune of 3 Million dollars invested in the retail shares since it became NDTP.
It is not retails fault the share price fell.

2) They do not even have a website now?

https://www.ndtpharmaceuticals.com/

Bullish
Bullish